Lunac Therapeutics
Leeds · Founded 2018
About Lunac Therapeutics
Epidarex Capital invests in early-stage, high growth life science and health technology Epidarex Capital is a transatlantic venture fund that invests in early-stage, high growth life science and health technology companies in under-ventured markets.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $14.3M
- Last round: Series Unknown (May 2021)
- Website: https://www.lunactherapeutics.com
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/lunac-therapeutics-154555 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.